News & Announcements
-
Holding(s) in Company
/**/ RNS Number : 0933I IQ-AI Limited 14 October 2024 TR-1: Standard form for notification of major holdings 1. IssuerDetails ISIN JE00BD4H0R42 Issuer Name IQ-AI LIMITED UK or Non-UK Issuer Non-UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Free Association
-
PDMR dealing and TR1 announcement
/**/ RNS Number : 0916I IQ-AI Limited 14 October 2024 PDMR dealing and TR1 announcement Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Trevor Brown 2 Reason for the notification a)
-
Acquisition of Interest by Braveheart
/**/ RNS Number : 8995H IQ-AI Limited 11 October 2024 11 October 2024 IQ-AI Limited IQ-AI Limited (“IQ-AI” or the “Company”) Acquisition of Interest by Braveheart Investment Group IQ-AI Limited (the “Company” or “IQ-AI”), the parent company of Wisconsin-based Imaging Biometrics, LLC (“IB”), which is focused on delivering quantitative imaging platforms and therapeutics that
-
Half-year Report
/**/ RNS Number : 3064A IQ-AI Limited 13 August 2024 13 August 2024 IQ-AI Limited (the “Company” or the “Group”) Half Yearly Report for the Period Ended 30 June 2024 The Board of IQ-AI Ltd is pleased to announce the Company’s half yearly report for the period ended 30 June 2024. For further information,
-
IB Opens Expanded Access Program
/**/ RNS Number : 7858T IQ-AI Limited 25 June 2024 June 25, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics Opens Expanded Access Program New cancer treatment with the potential to slow brain tumor growth is now available to patients in the US with relapsed/refractory histologic or molecular glioblastoma Imaging Biometrics, LLC